Press Releases

Date Title and Summary
Toggle Summary Accuray Customers Achieve Top Scores in AAPM MArkerless Lung Target Tracking CHallenge (MATCH) Using Synchrony® Technology on the Radixact® and CyberKnife® Systems
- American Association of Physicists in Medicine (AAPM) Grand Challenge MATCH event was designed to evaluate the potential to track lung tumor motion without fiducial markers in real-time during radiation therapy - Results demonstrate exceptional accuracy is achievable with the Accuray-only
Toggle Summary Accuray Continues to Set the Industry Standard for Customer Satisfaction
MD Buyline Report Shows Composite Overall User Satisfaction Ratings Exceed Industry Average for 14 Consecutive Quarters SUNNYVALE, Calif. , Jan. 19, 2017 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that its CyberKnife® and TomoTherapy® Systems continue to set the bar for
Toggle Summary Accuray Closes $70 Million Straight Debt Financing
SUNNYVALE, Calif. , Jan. 12, 2016 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today it has closed a $70 million straight debt financing agreement with Cerberus Business Finance, LLC , an affiliate of Cerberus Capital Management, L.P.
Toggle Summary Accuray ClearRT™ Helical Fan-Beam kVCT Imaging Wins "Best New Technology Solution for Oncology" MedTech Breakthrough Award
Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies SUNNYVALE, Calif. , May 5, 2022 /PRNewswire/ -- Accuray Incorporated  (NASDAQ: ARAY) announced today that its ClearRT ™ helical fan-beam kVCT imaging capability for the Radixact®  System has been
Toggle Summary Accuray CE Marks its New Radixact™ System
Next Generation Image-Guided Radiation Therapy Platform and Integrated Software Solutions are Now Available for Use by Clinicians in the European Union SUNNYVALE, Calif. , Aug. 9, 2016 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that it has CE marked its Radixact™ Treatment
Toggle Summary Accuray Board Approves Stock Repurchase Plan
SUNNYVALE, Calif., Aug. 30 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), today announced that its Board of Directors has approved a plan that authorizes the Company to repurchase shares of its common stock. Under the plan, the Company will have the ability to acquire up to $25
Toggle Summary Accuray Awarded Multi-System Order by 21st Century Oncology
SUNNYVALE, Calif. , Aug. 21, 2015 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today it has received a multi-system order from 21 st Century Oncology for one CyberKnife ® M6™ and four TomoHDA™ Systems. These are the latest generation CyberKnife and TomoTherapy Systems, and are
Toggle Summary Accuray Awarded $1 Million Grant by U.S. Government
Grant to fund Linear Accelerator Development for the Department of Homeland Security SUNNYVALE, Calif., Oct 05, 2010 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the company was awarded a $1 million Small Business
Toggle Summary Accuray Appoints Stan Gee VP of Revenue Management
SUNNYVALE, Calif. , May 24, 2017 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today it has appointed, Stan Gee , who has been with Accuray for over eight years, to the newly created Vice President of Revenue Management position reporting to Kevin Waters , Chief Financial Officer.
Toggle Summary Accuray Appoints Shig Hamamatsu Chief Financial Officer
SUNNYVALE, Calif. , Nov. 19, 2018 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that its Board of Directors has named Shig Hamamatsu as senior vice president, chief financial officer effective immediately. Mr. Hamamatsu joined Accuray as its vice president of finance and

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.